Synergistic effects of tamoxifen and cepharanthine for circumventing the multidrug resistance

This publication has 17 references indexed in Scilit:

• Interaction of tamoxifen with the multidrug resistance P-glycoprotein
  British Journal of Cancer, 1995
• High-Dose (480 mg/day) Tamoxifen with Etoposide: A Study of a Potential Multi-Drug Resistance Modulator
  Oncology, 1994
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms
  Cancer, 1992
• High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines
  British Journal of Cancer, 1992
• Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance
  European Journal Of Cancer, 1992
• Establishment of tumor cell lines from a patient with head and neck cancer and their different sensitivities to anti-cancer agents
  Cancer, 1989
• Chemosensitivity testing of human lung cancer cell lines using the MTT assay
  British Journal of Cancer, 1988
• Modification of cellular efflux and cytotoxicity of adriamycin by biscoclaulin alkaloid in vitro
  European Journal of Cancer and Clinical Oncology, 1987
• Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
  Journal of Immunological Methods, 1983